Tumor PD-L1 Triggers β2m Degradation to Evade Immunity
In a groundbreaking development that challenges prevailing paradigms of cancer immunotherapy resistance, researchers have unveiled a novel intrinsic mechanism by which tumor cells circumvent the...















